Published in Eur J Cardiovasc Prev Rehabil on October 01, 2010
Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort. Eur Heart J (2011) 1.18
Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol (2015) 1.00
Social class differences in secular trends in established coronary risk factors over 20 years: a cohort study of British men from 1978-80 to 1998-2000. PLoS One (2011) 0.87
Life-course body mass index trajectories and blood pressure in mid life in two British birth cohorts: stronger associations in the later-born generation. Int J Epidemiol (2015) 0.87
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension (2006) 11.68
Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) (1981) 11.00
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation (2004) 6.46
Regression to the mean: what it is and how to deal with it. Int J Epidemiol (2004) 6.29
Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart (1999) 4.04
Physical activity and ischaemic heart disease in middle-aged British men. Br Heart J (1991) 3.81
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension (2009) 3.40
How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation (2008) 3.13
Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J (2004) 2.91
The British Regional Heart Study 1975-2004. Int J Epidemiol (2004) 2.72
Revisiting Rose: strategies for reducing coronary heart disease. BMJ (2006) 2.53
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis (2008) 1.92
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart (2008) 1.89
Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart (2007) 1.87
The Dinamap 1846SX automated blood pressure recorder: comparison with the Hawksley random zero sphygmomanometer under field conditions. J Epidemiol Community Health (1992) 1.77
Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation (2005) 1.60
Non-attendance at re-examination 20 years after screening in the British Regional Heart Study. J Public Health Med (2002) 1.58
Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study. Hypertension (2007) 1.54
Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil (2006) 1.27
Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality. Heart (2002) 1.09
Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci (1999) 1.05
Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens (2002) 0.96
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol (2007) 7.13
Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation (2004) 6.46
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics (2005) 5.47
A consensus action agenda for achieving the national health information infrastructure. J Am Med Inform Assoc (2004) 5.44
Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA (2003) 5.32
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med (2005) 4.76
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet (2008) 4.70
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ (2011) 3.86
The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail (2002) 3.17
How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation (2008) 3.13
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J (2009) 2.89
Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation (2006) 2.89
Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr (2010) 2.82
Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation (2004) 2.81
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med (2003) 2.78
Physical activity and hemostatic and inflammatory variables in elderly men. Circulation (2002) 2.75
Social class differences in coronary heart disease in middle-aged British men: implications for prevention. Int J Epidemiol (2004) 2.68
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation (2009) 2.60
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59
Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr (2007) 2.55
Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc (2014) 2.46
Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol (2005) 2.43
The effect of breastfeeding on mean body mass index throughout life: a quantitative review of published and unpublished observational evidence. Am J Clin Nutr (2005) 2.43
Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J (2003) 2.38
The use of research evidence in public health decision making processes: systematic review. PLoS One (2011) 2.32
Does breastfeeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr (2006) 2.32
Infant feeding and blood cholesterol: a study in adolescents and a systematic review. Pediatrics (2002) 2.31
Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med (2011) 2.24
Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr (2006) 2.24
Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health (2011) 2.24
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J (2005) 2.21
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Patterns of body size and adiposity among UK children of South Asian, black African-Caribbean and white European origin: Child Heart And health Study in England (CHASE Study). Int J Epidemiol (2010) 2.12
Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med (2012) 2.07
Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med (2011) 2.07
Measures of adiposity in the identification of metabolic abnormalities in elderly men. Am J Clin Nutr (2005) 2.07
Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study. BMJ (2009) 2.05
Interactive computer-based interventions for sexual health promotion. Cochrane Database Syst Rev (2010) 2.04
Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr (2007) 1.93
Policy options to reduce population salt intake. BMJ (2011) 1.91
Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med (2012) 1.87
Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care (2009) 1.86
Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf (2010) 1.85
Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation (2009) 1.83
Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst (2012) 1.83
Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol (2011) 1.80
Remarkable decline in ischemic stroke mortality is not matched by changes in incidence. Stroke (2012) 1.79
Ethnic and gender differences in physical activity levels among 9-10-year-old children of white European, South Asian and African-Caribbean origin: the Child Heart Health Study in England (CHASE Study). Int J Epidemiol (2009) 1.78
Doctors' perceptions of palliative care for heart failure: focus group study. BMJ (2002) 1.73
Trends in blood pressure in 9 to 11-year-old children in the United Kingdom 1980-2008: the impact of obesity. J Hypertens (2012) 1.73
Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care (2005) 1.73
Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration. Eur Heart J (2011) 1.73
APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med (2005) 1.70
Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ (2012) 1.69
Reconstructing the population genetic history of the Caribbean. PLoS Genet (2013) 1.68
Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci (2006) 1.67
Adipokines and risk of type 2 diabetes in older men. Diabetes Care (2007) 1.63
Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am J Clin Nutr (2010) 1.61
Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol (2011) 1.61
Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet (2006) 1.59
Are childhood socio-economic circumstances related to coronary heart disease risk? Findings from a population-based study of older men. Int J Epidemiol (2007) 1.59
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health (2005) 1.57